Alaa Samara currently serves as the Director of Market Access for the Middle East at Abbott Diabetes Care, where he plays a pivotal role in the strategic direction and operational execution of the Freestyle Libre product line. With over 20 years of diversified experience in...
Alaa Samara currently serves as the Director of Market Access for the Middle East at Abbott Diabetes Care, where he plays a pivotal role in the strategic direction and operational execution of the Freestyle Libre product line. With over 20 years of diversified experience in the medical devices, pharmaceuticals, and biopharmaceutical sectors, Alaa has honed his expertise in leading business turnarounds and driving successful product launches. His leadership is characterized by a deep understanding of market dynamics and a commitment to enhancing patient outcomes through innovative diabetes management solutions.
In his current role, Alaa is instrumental in navigating the complexities of market access across various Middle Eastern countries, ensuring that the Freestyle Libre system is not only accessible but also effectively integrated into healthcare systems. He leads cross-functional teams in developing and executing comprehensive business strategies that align with Abbott's mission to improve the lives of people with diabetes. His skills in key account management and marketing enable him to build strong relationships with healthcare providers and stakeholders, fostering collaboration that drives adoption and utilization of the Freestyle Libre technology.
Alaa’s approach to leadership emphasizes people development and change management, empowering his teams to embrace innovation and adapt to the evolving healthcare landscape. His strategic vision and operational acumen have positioned Abbott as a leader in diabetes care, making significant strides in improving patient adherence and outcomes. As the diabetes care market continues to evolve, Alaa remains at the forefront, leveraging his extensive experience to drive impactful initiatives that enhance the quality of life for individuals living with diabetes in the Middle East.
